Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.27 Up 0.01(4.20%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 76   36   36   36  
Cost of Revenue323  156  252  635  
Gross Profit (247) (120) (216) (599)
Operating Expenses
Research Development2,326  1,533  2,173  2,318  
Selling General and Administrative2,539  1,759  2,070  1,817  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,112) (3,412) (4,459) (4,734)
Income from Continuing Operations
Total Other Income/Expenses Net1,279  219  (673)456  
Earnings Before Interest And Taxes(3,833)(3,193)(5,132)(4,278)
Interest Expense3  2  4  5  
Income Before Tax(3,836)(3,195)(5,136)(4,283)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,836)(3,195)(5,136)(4,283)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,836) (3,195) (5,136) (4,283)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,836) (3,195) (5,136) (4,283)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.